Potassium%25252525252520chloride

# Potassium Chloride ## Overview Potassium chloride (KCL) is an electrolyte supplement used to prevent or treat hypokalemia. ## Primary Indications * Treatment and prevention of hypokalemia. ## Adult Dosing * **Prevention of hypokalemia:** Typically 20-40 mEq (1.5-3 g) per day in divided doses. * **Treatment of hypokalemia:** Doses vary widely based on severity, serum potassium levels, and patient response. Mild to moderate hypokalemia may be treated with 40-100 mEq (3-7.5 g) per day in divided doses. Severe hypokalemia or hypokalemia accompanied by cardiac abnormalities requires more aggressive dosing, often intravenously, and should be guided by local protocol and close monitoring. * **Maximum oral dose:** Generally not to exceed 20 mEq (1.5 g) per single dose or 100 mEq (7.5 g) per day, unless dictated by specific clinical circumstances and close monitoring. Intravenous administration has specific rate and concentration limits to prevent cardiac toxicity. ## Pediatric Dosing * **Prevention of hypokalemia:** 1-2 mEq/kg/day in divided doses, not to exceed the adult maximum of 100 mEq/day. * **Treatment of hypokalemia:** Doses vary based on severity, serum potassium, and clinical status. Often 2-5 mEq/kg/day in divided doses. Severe cases may require intravenous administration under strict monitoring, with specific guidelines often dictated by local protocols. ## Dose Adjustments * **Renal impairment:** Dose reduction is necessary. Use with caution and monitor potassium levels closely. * **Adrenal insufficiency:** Dose reduction may be needed. ## Contraindications * Hyperkalemia. * Conditions causing increased potassium levels (e.g., severe renal impairment, untreated Addison's disease, severe tissue trauma, certain diuretic use). * Anuria, oliguria, or azotemia. * Gastrointestinal obstruction or paralysis. ## Adverse Effects * **Gastrointestinal:** Nausea, vomiting, abdominal pain, diarrhea, flatulence. Esophageal or gastric irritation or ulceration can occur, particularly with rapid release formulations or inadequate fluid intake. * **Cardiovascular:** Arrhythmias, cardiac arrest (especially with rapid IV administration or hyperkalemia). * **Other:** Hyperkalemia, paresthesia. ## Key Drug Interactions * **Potassium-sparing diuretics (e.g., spironolactone, amiloride, triamterene):** Increased risk of hyperkalemia. * **ACE inhibitors (e.g., lisinopril, enalapril) and ARBs (e.g., losartan, valsartan):** Increased risk of hyperkalemia. * **NSAIDs (e.g., ibuprofen, naproxen):** Can reduce the antihypertensive effect of diuretics and increase the risk of hyperkalemia. * **Digitalis glycosides:** Hypokalemia can increase the toxicity of digitalis; hyperkalemia can decrease toxicity. ## Monitoring * Serum potassium levels (frequent monitoring is essential, especially with IV administration, severe hypokalemia, or renal impairment). * Renal function (BUN, creatinine). * ECG (especially with IV administration or significant electrolyte shifts). * Signs and symptoms of hypokalemia and hyperkalemia. ## Clinical Pearls * Oral potassium chloride should be taken with meals or after meals to minimize gastrointestinal upset. * Dilute liquid preparations or dissolve solid forms in adequate amounts of water or juice before administration. * Rapid intravenous infusion or high concentrations can cause cardiac arrest. Follow strict guidelines for IV administration. * The ideal dose for oral or IV treatment of hypokalemia in both adults and pediatrics can depend significantly on the severity of the deficit, serum potassium concentration, acid-base balance, and the presence of other electrolyte abnormalities. *** **Disclaimer:** This information is for educational purposes only and does not substitute for professional medical advice. Always consult with a qualified healthcare provider to determine the appropriateness of any medication or treatment for your specific condition. Verify current prescribing information with the manufacturer's package insert or other reliable sources before making any clinical decisions.